Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Double-blind, Placebo-controlled Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease

NCT00445939 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00445939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00445939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Double-blind, Placebo-controlled Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease
Lead sponsor
Abbott
Phase
Phase 2/3
Overall status
Completed
Start date
February 28, 2007
Completion date
Not reported
Enrollment
90 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease